A2RYL1 AF NFT

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeibpmxrky34dxtph76w2sgmapr3higc7j6be6r3qzhfyvocpbyumq4/metadata.json
IPFS of structure file: 
bafybeih26bbg2yqrsn2r4env3r355sbr4vqnoqx6h2iq66eqt4qcdsocxe/AF-A2RYL1-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x5B801Fb1E3C9B742E47a76772D05a9Ed224A0f1D
First NFT owner address (bech32): 
genesis1twqplv0rexm59er6wemj6pdfa53y5rcaqn0hw3
Current NFT ID #166493 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
166493
Accession (UniProt):
A2RYL1
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
Burkholderia mallei (strain NCTC 10229)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A2RYL1 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A2RYL1|HEM1_BURM9 Glutamyl-tRNA reductase OS=Burkholderia mallei (strain NCTC 10229) OX=412022 GN=hemA PE=3 SV=1 MDMQLLTIGINHHTAPVALRERVAFPLEQIKPALSTFKSVFLGHPAPNAPEAAILSTCNRTELYCATNDRAARDAAIRWMSDYHRIPADELAPHVYALPQSEAVRHAFRVASGLDSMVLGETQILGQMKNAVRTASEAGSLGTYLNQLFQRTFAVAKEVRGTTEIGAQSVSMAAAAVRLAQRIFEQVAQQRVLFIGAGEMIELCATHFAAQGPRELVVANRTAERGAKLAERFGGRAMPLADLPARMHEFDIIVSCTASTLPIIGLGAVERAVKARRHRPIFMVDLAVPRDIEPEVGKLKDVFLYTVDDLGAIVREGNASRQAAVAQAEAIIETRVQNFMQWLDARSIVPVIRHMHTQADALRRAEVERARKMLARGDDPDAVLDALSQALTNKLIHGPTSALNRANGADRDSLIDLMRGFYQHAPRSSDTSDR